乳腺癌腋窝淋巴结评估:最新进展
腋窝淋巴结转移是乳腺癌总复发和生存的最重要预测因素,准确评估腋窝淋巴结受累是分期关键。随着前哨淋巴结活检引入,腋窝管理更微创和个体化,新证据提示部分淋巴结阳性及阴性患者可避免腋窝淋巴结清扫。腋窝超声、MRI和超声引导活检用于评估淋巴结病变负荷以指导多学科治疗决策,新辅助化疗后淋巴结阳性患者推荐超声和MRI再分期及靶向腋窝清扫联合前哨淋巴结活检以降低假阴性率。
要点
- 腋窝超声、MRI和超声引导活检是评估腋窝淋巴结病变负荷、指导多学科治疗决策的关键影像手段。
- 新辅助化疗后的淋巴结阳性患者,推荐超声和MRI再分期及靶向腋窝清扫联合前哨淋巴结活检以降低前哨淋巴结活检假阴性率。
- 影像特征整合的预测模型正在开发中,用于预测淋巴结病变负荷并筛选适合前哨淋巴结活检的候选者。
临床应用与阅片要点
- 腋窝超声、MRI和超声引导活检可用于评估腋窝淋巴结病变负荷,以指导多学科治疗决策。
- 对新辅助化疗后的淋巴结阳性患者,推荐超声和MRI再分期及靶向腋窝清扫联合前哨淋巴结活检,以降低前哨淋巴结活检假阴性率。
- 正在开发整合影像特征的预测模型,以预测淋巴结病变负荷并筛选适合前哨淋巴结活检的候选者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Axillary lymph node (LN) metastasis is the most important predictor of overall recurrence and survival in patients with breast cancer, and accurate assessment of axillary LN involvement is an essential component in staging breast cancer. Axillary management in patients with breast cancer has become much less invasive and individualized with the introduction of sentinel LN biopsy (SLNB). Emerging evidence indicates that axillary LN dissection may be avoided in selected patients with node-positive as well as node-negative cancer. Thus, assessment of nodal disease burden to guide multidisciplinary treatment decision making is now considered to be a critical role of axillary imaging and can be achieved with axillary US, MRI, and US-guided biopsy. For the node-positive patients treated with neoadjuvant chemotherapy, restaging of the axilla with US and MRI and targeted axillary dissection in addition to SLNB is highly recommended to minimize the false-negative rate of SLNB. Efforts continue to develop prediction models that incorporate imaging features to predict nodal disease burden and to select proper candidates for SLNB. As methods of axillary nodal evaluation evolve, breast radiologists and surgeons must work closely to maximize the potential role of imaging and to provide the most optimized treatment for patients.
引用
- Chang JM, Leung JWT, Moy L, et al. Axillary Nodal Evaluation in Breast Cancer: State of the Art. Radiology. 2020. PMID: 32315268. doi:10.1148/radiol.2020192534
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。